Alnylam Reports Positive Phase II Data for ALN-TTR02, an RNAi Therapeutic

News   Jul 01, 2013

 
Alnylam Reports Positive Phase II Data for ALN-TTR02, an RNAi Therapeutic
 
 
 

RELATED ARTICLES

Fight Against Cancer: Drug Combination Helps Kickstart the Immune System

News

Scientists from King's College London have found a way to boost the immune system to help it fight back against cancer.

The breakthrough involves the first ever use of a combination of chemotherapy and a drug being trialled as a treatment for neonatal jaundice, that together help kick start the body's natural defences.

READ MORE

How We Sense Touch: Skin cells communicate with nerve cells

News

The study in mice paves the way for future research into the skin–nerve–brain communication errors that occur in disorders such as dermatitis and psoriasis and could inform the development of new topical treatments for these conditions.

READ MORE

The BuzzBuster: Could Gene Silencing Help Silence the Housefly?

News

Gene silencing dsRNA technology can reduce housefly fertility, showing promise as a pest-control method.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE